Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Noninvasive assessment of airway inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164 Year: 2003
Additive contribution of exhaled nitric oxide and sputum eosinophils to airway responsiveness Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
Comparison of exhaled nitric oxide values measured by two offline methods or NO breath Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways? Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Diagnostic value of induced sputum and nitric oxide in exhaled breath condensate to control treatment of bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 503s Year: 2006
Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005
Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006
Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Determine the relationship between fraction exhaled nitric oxide (FeNO) and mannitol challenge test in the diagnosis of suspected asthma patients. Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020
Validity of the fractional exhaled nitric oxide (FENO ) for identification of bronchial hyperresponsiveness in a pulmonary function laboratory Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013